Effects of cannabidiol in alcohol use disorder patients with and without co-occurring post-traumatic stress disorder: Tolerability but no evidence for efficacy in two randomized proof-of-concept trials.

Figure 4 displays scatterplots of the observed nominally significant associations of week 4 CBD levels with BDI‐II scores, PHDD, and DPD.

also in 2,741 other papers

derate to severe non‐nicotine substance use disorder or any current cannabis use disorder, current pregnancy or lactation, urine drug screen positive for THC, cocaine or opioids or current use of exclusionary medications, including any pharmacotherapy for alcohol use disorder or any medication with possibly significant pharmacokinetic interactions with CBD.

also in 164 other papers